Critical Path for Alzheimer’s Disease 2020 Annual Meeting and Regulatory Science Workshop – Virtual
October 27, 2020
9:30 a.m. – 1 p.m. (US Eastern Time)
The Critical Path for Alzheimer’s Disease (CPAD) is a Critical Path Institute public-private partnership aimed at generating actionable solutions and knowledge towards advancing drug development across the AD continuum.
The key objectives of the meeting are:
- Scientific dialogue to guide the strategic development of comprehensive disease progression models spanning the AD continuum by utilizing advanced quantitative modeling methodology, such as nonlinear mixed effects approaches, artificial intelligence, and machine learning.
- Achieve consensus on gaining actionable information from fluid and imaging biomarker data for use in quantitative analysis and disease progression modeling, for the purpose of developing regulatory-endorsed modelinformed quantitative Drug Development Tools in Alzheimer’s Disease.
Access the full agenda here.